Sarepta Therapeutics, Inc.

Neuromuscular-focused biotech with approved Duchenne gene and exon-skipping therapies plus additional gene-therapy programs.

Back to company catalog

Neuromuscular rare disease · AAV gene therapy & exon-skipping oligonucleotides · Commercial + clinical

Compare report options